drugset / Trial / NCT06709820
A Study of LY4060874 in Healthy Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to evaluate safety and tolerability of LY4060874 in healthy participants. Study participation may last up to 22 weeks and up to approximately 18 study visits.
Timeline
- Start
- 2024-12-02
- Primary completion
- 2026-02-20
- Completion
- 2026-02-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY4060874 | Unknown | — | Subcutaneous |
Indications
No indication recorded.